Suppr超能文献

对去唾液酸糖蛋白分解代谢的内吞途径的抑制作用。

Inhibition of the endocytic pathway for asialoglycoprotein catabolism.

作者信息

Harford J, Klausner R D, Ashwell G

出版信息

Biol Cell. 1984;51(2):173-9. doi: 10.1111/j.1768-322x.1984.tb00296.x.

Abstract

Rat hepatocytes in primary culture bind, internalize and eventually degrade asialoglycoproteins. This process is mediated by a specific receptor in the hepatocyte plasma membrane. The endocytic pathway by which ligand molecules are translocated to lysosomes has been examined by the development of biological assays capable of distinguishing ligand populations at various points in the process. Inhibitors have been identified that perturb particular transitions that define the endocytic pathway. In the present paper, inhibition by the bacterial tripeptide leupeptin is compared to the effect of colchine plus cytochalasin B. The latter combination impedes intracellular segregation of ligand and receptor while leupeptin inhibits intralysosomal proteolysis. However, evidence is presented to indicate that the inhibitory effects colchine plus cytochaasin B consists of at least two components. One component is independent of the presence of ligand whereas the other is observed only when ligand is present together with the drugs.

摘要

原代培养的大鼠肝细胞能够结合、内化并最终降解去唾液酸糖蛋白。这一过程由肝细胞膜中的一种特异性受体介导。通过开发能够区分该过程中不同阶段配体群体的生物学检测方法,对配体分子转运至溶酶体的内吞途径进行了研究。已鉴定出干扰定义内吞途径的特定转变的抑制剂。在本文中,将细菌三肽亮抑酶肽的抑制作用与秋水仙碱加细胞松弛素B的作用进行了比较。后一种组合会阻碍配体和受体在细胞内的分离,而亮抑酶肽则抑制溶酶体内的蛋白水解。然而,有证据表明秋水仙碱加细胞松弛素B的抑制作用至少由两个成分组成。一个成分与配体的存在无关,而另一个成分仅在配体与药物同时存在时才会出现。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验